These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24324553)

  • 21. Low-frequency collective motion of DNA-binding domain defines p53 function.
    Zhang G; Tang C; Pan L; Lü J
    Proteins; 2022 Mar; 90(3):881-888. PubMed ID: 34792219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structures of the DNA-binding domain tetramer of the p53 tumor suppressor family member p73 bound to different full-site response elements.
    Ethayathulla AS; Nguyen HT; Viadiu H
    J Biol Chem; 2013 Feb; 288(7):4744-54. PubMed ID: 23243311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.
    Rustandi RR; Baldisseri DM; Drohat AC; Weber DJ
    Protein Sci; 1999 Sep; 8(9):1743-51. PubMed ID: 10493575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural differences in the DNA binding domains of human p53 and its C. elegans ortholog Cep-1.
    Huyen Y; Jeffrey PD; Derry WB; Rothman JH; Pavletich NP; Stavridi ES; Halazonetis TD
    Structure; 2004 Jul; 12(7):1237-43. PubMed ID: 15242600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation.
    Mujtaba S; He Y; Zeng L; Yan S; Plotnikova O; Sachchidanand ; Sanchez R; Zeleznik-Le NJ; Ronai Z; Zhou MM
    Mol Cell; 2004 Jan; 13(2):251-63. PubMed ID: 14759370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of the anticancer p28 peptide with p53-DBD as studied by fluorescence, FRET, docking and MD simulations.
    Bizzarri AR; Moscetti I; Cannistraro S
    Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):342-350. PubMed ID: 30419285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of the mouse p53 core DNA-binding domain at 2.7 A resolution.
    Zhao K; Chai X; Johnston K; Clements A; Marmorstein R
    J Biol Chem; 2001 Apr; 276(15):12120-7. PubMed ID: 11152481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferred drifting along the DNA major groove and cooperative anchoring of the p53 core domain: mechanisms and scenarios.
    Pan Y; Nussinov R
    J Mol Recognit; 2010; 23(2):232-40. PubMed ID: 19856322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dimerization of the core domain of the p53 family: a computational study.
    Madhumalar A; Jun LH; Lane DP; Verma CS
    Cell Cycle; 2009 Jan; 8(1):137-48. PubMed ID: 19106606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solution structure of the tetrameric minimum transforming domain of p53.
    Lee W; Harvey TS; Yin Y; Yau P; Litchfield D; Arrowsmith CH
    Nat Struct Biol; 1994 Dec; 1(12):877-90. PubMed ID: 7773777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Full-length p53 tetramer bound to DNA and its quaternary dynamics.
    Demir Ö; Ieong PU; Amaro RE
    Oncogene; 2017 Mar; 36(10):1451-1460. PubMed ID: 27641333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common cancer mutations R175H and R273H drive the p53 DNA-binding domain towards aggregation-prone conformations.
    Li L; Li X; Tang Y; Lao Z; Lei J; Wei G
    Phys Chem Chem Phys; 2020 May; 22(17):9225-9232. PubMed ID: 32307496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational dynamics and molecular recognition: backbone dynamics of the estrogen receptor DNA-binding domain.
    Wikström A; Berglund H; Hambraeus C; van den Berg S; Härd T
    J Mol Biol; 1999 Jun; 289(4):963-79. PubMed ID: 10369775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors governing loss and rescue of DNA binding upon single and double mutations in the p53 core domain.
    Wright JD; Noskov SY; Lim C
    Nucleic Acids Res; 2002 Apr; 30(7):1563-74. PubMed ID: 11917017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating Conformational Dynamics and Allostery in the p53 DNA-Binding Domain Using Molecular Simulations.
    Papaleo E
    Methods Mol Biol; 2021; 2253():221-244. PubMed ID: 33315226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer-related Mutations with Local or Long-range Effects on an Allosteric Loop of p53.
    Degn K; Beltrame L; Dahl Hede F; Sora V; Nicolaci V; Vabistsevits M; Schmiegelow K; Wadt K; Tiberti M; Lambrughi M; Papaleo E
    J Mol Biol; 2022 Sep; 434(17):167663. PubMed ID: 35659507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p28, an anionic cell-penetrating peptide, increases the activity of wild type and mutated p53 without altering its conformation.
    Yamada T; Das Gupta TK; Beattie CW
    Mol Pharm; 2013 Sep; 10(9):3375-83. PubMed ID: 23952735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insight into a novel p53 single point mutation (G389E) by Molecular Dynamics Simulations.
    Pirolli D; Carelli Alinovi C; Capoluongo E; Satta MA; Concolino P; Giardina B; De Rosa MC
    Int J Mol Sci; 2010 Dec; 12(1):128-40. PubMed ID: 21339981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hot-spot mutants of p53 core domain evince characteristic local structural changes.
    Wong KB; DeDecker BS; Freund SM; Proctor MR; Bycroft M; Fersht AR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8438-42. PubMed ID: 10411893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.